Replies to post #158957 on Biotech Values

[DewDiligence]

FDA denied TEVA's CP regarding new MS drug approval without input from adcom...

The quick (<3 months) FDA turnaround on Teva’s rejected CP is clearly tied to the approval of Tecfidera.